A detailed history of Arlington Partners LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Arlington Partners LLC holds 36,155 shares of ABT stock, worth $4.1 Million. This represents 1.71% of its overall portfolio holdings.

Number of Shares
36,155
Previous 30,580 18.23%
Holding current value
$4.1 Million
Previous $3.18 Million 29.75%
% of portfolio
1.71%
Previous 1.68%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$100.07 - $118.13 $557,890 - $658,574
5,575 Added 18.23%
36,155 $4.12 Million
Q2 2024

Aug 01, 2024

BUY
$100.73 - $112.44 $293,728 - $327,875
2,916 Added 10.54%
30,580 $3.18 Million
Q1 2024

Apr 16, 2024

SELL
$109.52 - $120.96 $389,781 - $430,496
-3,559 Reduced 11.4%
27,664 $3.14 Million
Q4 2023

Jan 24, 2024

BUY
$90.19 - $110.4 $2.82 Million - $3.45 Million
31,223 New
31,223 $3.44 Million
Q2 2023

Jul 26, 2023

BUY
$100.78 - $112.29 $178,682 - $199,090
1,773 Added 132.31%
3,113 $339,000
Q1 2023

Apr 26, 2023

BUY
$96.86 - $114.01 $21,018 - $24,740
217 Added 19.32%
1,340 $135,000
Q4 2021

Jan 18, 2022

BUY
$115.53 - $141.46 $68,740 - $84,168
595 Added 112.69%
1,123 $158,000
Q2 2020

Jul 13, 2020

BUY
$76.57 - $98.0 $37,289 - $47,726
487 Added 1187.8%
528 $48,000
Q1 2020

Apr 13, 2020

BUY
$62.82 - $91.86 $2,575 - $3,766
41 New
41 $3,000
Q4 2018

Jan 10, 2019

SELL
$65.56 - $74.27 $65,691 - $74,418
-1,002 Closed
0 $0
Q3 2018

Oct 23, 2018

BUY
$60.81 - $73.36 $60,931 - $73,506
1,002 New
1,002 $74,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Arlington Partners LLC Portfolio

Follow Arlington Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arlington Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arlington Partners LLC with notifications on news.